(NX) Quanex Building Products - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7476191041

NX: Windows, Doors, Insulation, Cabinets, Solar, Fencing, Decking

Quanex Building Products Corporation (NYSE:NX) is a key player in the fenestration industry, specializing in components for windows, doors, and cabinet systems. With operations spanning North America, Europe, and Asia, the company serves a diverse range of markets, from residential construction to commercial building projects. Its product portfolio includes essential components like insulating glass spacers, vinyl profiles, and precision-formed metal products, all critical for energy efficiency and structural integrity in modern buildings.

Quanex operates through three primary segments: North American Fenestration, European Fenestration, and North American Cabinet Components. This segmentation allows the company to cater to regional market demands while maintaining operational efficiency. Beyond its core fenestration products, Quanex also manufactures non-fenestration components such as solar panel sealants, vinyl decking, and water retention barriers, diversifying its revenue streams and reducing dependence on a single market.

The company’s financial health is reflected in its market capitalization of $1.007 billion, with a trailing P/E ratio of 23.71 and a forward P/E of 9.77, indicating expectations of future earnings growth. The price-to-book ratio of 1.03 suggests the market values the company’s assets at a modest premium, while the price-to-sales ratio of 0.93 points to a reasonable valuation relative to its revenues.

Quanex’s customer base includes original equipment manufacturers (OEMs) in the building products industry, with sales facilitated through a mix of direct sales forces, distributors, and independent agents. This multi-channel approach ensures broad market reach and customer accessibility. Founded in 1927 and headquartered in Houston, Texas, Quanex has established itself as a

Additional Sources for NX Stock

NX Stock Overview

Market Cap in USD 979m
Sector Industrials
Industry Building Products & Equipment
GiC Sub-Industry Building Products
IPO / Inception 1987-12-30

NX Stock Ratings

Growth 5y 11.2%
Fundamental -16.9%
Dividend 38.0%
Rel. Strength Industry -40.3
Analysts 5/5
Fair Price Momentum 15.94 USD
Fair Price DCF 23.77 USD

NX Dividends

Dividend Yield 12m 1.28%
Yield on Cost 5y 1.80%
Annual Growth 5y 0.00%
Payout Consistency 95.1%

NX Growth Ratios

Growth Correlation 3m -92.9%
Growth Correlation 12m -79.8%
Growth Correlation 5y 73.1%
CAGR 5y 2.77%
CAGR/Max DD 5y 0.05
Sharpe Ratio 12m -0.97
Alpha -52.17
Beta 0.58
Volatility 42.37%
Current Volume 593.3k
Average Volume 20d 460.7k
What is the price of NX stocks?
As of February 23, 2025, the stock is trading at USD 20.38 with a total of 593,268 shares traded.
Over the past week, the price has changed by -11.74%, over one month by -15.61%, over three months by -32.03% and over the past year by -37.37%.
Is Quanex Building Products a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Quanex Building Products is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NX as of February 2025 is 15.94. This means that NX is currently overvalued and has a potential downside of -21.79%.
Is NX a buy, sell or hold?
Quanex Building Products has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy NX.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NX stock price target?
According to ValueRays Forecast Model, NX Quanex Building Products will be worth about 17.8 in February 2026. The stock is currently trading at 20.38. This means that the stock has a potential downside of -12.76%.
Issuer Forecast Upside
Wallstreet Target Price 36.5 79.1%
Analysts Target Price 36.3 78.3%
ValueRay Target Price 17.8 -12.8%